Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phentolamine Mesylate Eye Drops in Severe Night Vision Disturbances
NCT04004507Phase 2Completed
- Sponsor
- Opus Genetics
- Start
- Aug 2007
- Primary completion
- Oct 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in nyctalopia comparing Phentolamine Mesylate Ophthalmic Solution 1% with Phentolamine Mesylate Ophthalmic Solution Vehicle (2 arms). Primary endpoint: Contrast Sensitivity at 1 day. Started Aug 2007; status: completed.
02
Drugs
phentolamine
03
Conditions
nyctalopia
Beyond the preview
Go deeper on NCT04004507.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04004507.